Table 1

Distribution of age, aetiology, diagnostic tests and pattern of treatment among paroxysmal atrial fibrillation patients by sex

Female

Male

n = 268

(%)

n = 257

(%)


Age

40–59

30

(11.2)

63

(24.5)

60–69

57

(21.3)

74

(28.8)

70–79

107

(39.9)

81

(31.5)

80+

74

(27.6)

39

(15.2)

AF aetiology assigned by the GP*

IHD

117

(43.7)

110

(42.8)

Valvular

24

(9.0)

13

(5.1)

Other cardiac diseases

19

(7.1)

20

(7.8)

Non-cardiac diseases

28

(10.4)

16

(10.1)

Unknown

80

(29.9)

88

(34.2)

Tests done to confirm diagnosis

ECG alone

158

(59.0)

170

(66.1)

Other test (with/without ECG)

46

(17.1)

33

(12.8)

Unknown

64

(23.9)

54

(21.0)

Cardioversion attempts

No or unknown

178

(66.4)

170

(66.2)

Pharmacological only

79

(29.5)

69

(26.8)

Electrical only

8

(3.0)

13

(5.1)

Both

3

(1.1)

5

(1.9)

Use of AF treatment drugs †

Amiodarone

27

(10.1)

40

(15.6)

Verapamil

8

(3.0)

7

(2.7)

Diltiazem

13

(4.9)

13

(5.1)

Beta-blockers

82

(30.6)

65

(25.3)

Digoxin

100

(37.3)

80

(31.1)

Use of antithrombotics/anticoagulants†

No use

136

(50.7)

115

(44.7)

Warfarin only

28

(10.4)

36

(14.0)

Aspirin only

92

(34.3)

91

(35.4)

Both

12

(4.5)

15

(5.8)


*17 cases (3.2%) had the episode after a cardiovascular surgery.

†In the first 3 months after initial diagnosis.

Ruigómez et al. BMC Cardiovascular Disorders 2005 5:20   doi:10.1186/1471-2261-5-20

Open Data